Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-06
1995-06-20
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514272, 544320, 544321, 544324, 544325, 544331, 544332, A61K 31505, C07D23942, C07D23948, C07D40112
Patent
active
054261104
ABSTRACT:
The present invention provides novel pyrimidinyl-glutamic acid derivatives and intermediates thereto. Further provided are methods for inhibiting dihydrofolate reductase in mammals and for treating susceptible neoplasms in mammals, particularly humans.
REFERENCES:
patent: 4684653 (1987-08-01), Taylor et al.
patent: 4871743 (1989-10-01), Taylor et al.
patent: 4920125 (1990-04-01), Taylor et al.
Weinstock, et al., J. Med. Chem. 11(6):1238-1241 (1968).
Stuart, et al., J. Med. Chem., 26:667-673 (1983).
Taylor, et al., Heterocycles, 28(2):1169-1178 (1989).
Taylor et al., Chemical Abstracts, vol. 117, entry 212902e (1992).
Taylor et al., Chemical Abstracts, vol. 116, entry 152317k (1992).
Akimoto et al, Chemical Abstracts, vol. 115, entry 29364a (1990).
Gossett Lynn S.
Shih Chuan
Boone David E.
Conrad Robert A.
Eli Lilly and Company
Fontana Steven A.
Ford John M.
LandOfFree
Pyrimidinyl-glutamic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidinyl-glutamic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidinyl-glutamic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1844299